digoxigenin has been researched along with Atypical Ductal Hyperplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bast, RC; Hoque, A; Lippman, SM; Liu, J; Lu, Z; Luo, RZ; Nishimoto, A; Sahin, AA; Wang, L; Yu, Y; Yuan, J | 1 |
Bolkent, S; Kaner, G; Oztürk, M; Unal, H; Yilmazer, S | 1 |
2 other study(ies) available for digoxigenin and Atypical Ductal Hyperplasia
Article | Year |
---|---|
Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Topics: Adult; Aged; Antibodies, Monoclonal; Blotting, Western; Breast; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cytoplasm; Digoxigenin; Disease Progression; DNA, Complementary; Down-Regulation; Female; Genes, Tumor Suppressor; Humans; Immunohistochemistry; In Situ Hybridization; Middle Aged; Reverse Transcriptase Polymerase Chain Reaction; rho GTP-Binding Proteins; RNA; RNA, Messenger; Sensitivity and Specificity; Transfection | 2003 |
Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltrating; Carcinoma, Papillary; Digoxigenin; Female; Gene Amplification; Gene Expression; Genes, erbB-2; Humans; Immunohistochemistry; In Situ Hybridization; Oligonucleotide Probes; Prognosis; RNA, Messenger; RNA, Neoplasm | 1998 |